ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,630 | -24.6% | 805 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $28,706 | +40.4% | 805 | 0.0% | 0.00% | +50.0% |
| Q1 2023 | $20,447 | -37.4% | 805 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $32,651 | +20.9% | 805 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $27,000 | -3.6% | 805 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $28,000 | -24.3% | 805 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $37,000 | -30.2% | 805 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $53,000 | -8.6% | 805 | -13.4% | 0.01% | -14.3% |
| Q3 2021 | $58,000 | -24.7% | 930 | 0.0% | 0.01% | -36.4% |
| Q2 2021 | $77,000 | -99.8% | 930 | +36.8% | 0.01% | +37.5% |
| Q1 2021 | $45,091,000 | +86613.5% | 680 | 0.0% | 0.01% | -27.3% |
| Q4 2020 | $52,000 | +79.3% | 680 | 0.0% | 0.01% | +37.5% |
| Q3 2020 | $29,000 | 0.0% | 680 | 0.0% | 0.01% | -11.1% |
| Q2 2020 | $29,000 | +45.0% | 680 | 0.0% | 0.01% | +28.6% |
| Q1 2020 | $20,000 | -76.7% | 680 | -50.0% | 0.01% | -53.3% |
| Q4 2019 | $86,000 | +352.6% | 1,360 | +100.0% | 0.02% | +150.0% |
| Q3 2019 | $19,000 | -44.1% | 680 | -47.7% | 0.01% | -50.0% |
| Q2 2019 | $34,000 | – | 1,299 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |